IOBT
$1.39
Net Profits | $-21.18Mn |
Io Biotech, Inc.’s net profit fell -14.51% since last year same period to $-21.18Mn in the Q2 2023. On a quarterly growth basis, Io Biotech, Inc. has generated -24.25% fall in its net profits since last 3-months.
EPS Estimate Current Quarter | -0.71 |
EPS Estimate Current Year | -0.71 |
Io Biotech, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.71 - a 3.62% jump from last quarter’s estimates.
Io Biotech, Inc.’s earning per share (EPS) estimates for the current year stand at -0.71.
Earning Per Share (EPS) | 0 |
Io Biotech, Inc.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2023. This indicates that the Io Biotech, Inc. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-08-11 | -0.74 | 0 | 100% |
2023-11-08 | -0.71 | 0 | 100% |
2023-05-11 | -0.76 | 0 | 100% |